Are there any new FDA approved treatments for chronic insomnia that don't carry a high risk of dependency for young adults?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Are there any new FDA approved treatments for chronic insomnia that don't carry a high risk of dependency for young adults?
3 real searches · 1 real-search pass
FDA approved chronic insomnia treatments 2025 daridorexant lemborexant ramelteon doxepin dependence abuse schedule IVGoogle ↗
OBSERVED
FDA prescribing information daridorexant lemborexant abuse dependence schedule IV chronic insomniaGoogle ↗
OBSERVED
AASM clinical practice guideline chronic insomnia CBT-I ramelteon doxepin orexin receptor antagonistGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
FDA approved chronic insomnia treatments 2025 daridorexant lemborexant ramelteon doxepin dependence abuse schedule IV Google ↗
FDA prescribing information daridorexant lemborexant abuse dependence schedule IV chronic insomnia Google ↗
AASM clinical practice guideline chronic insomnia CBT-I ramelteon doxepin orexin receptor antagonist Google ↗
- DailyMed · dailymed.nlm.nih.gov
- label · accessdata.fda.gov
- DailyMed · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use ROZEREM® safely and effectively. See full prescribing information for ROZEREM. ROZEREM (ramelteon) tablets, for oral use Initial U.S. Approval: 2005 · dailymed.nlm.nih.gov
- DailyMed · dailymed.nlm.nih.gov
- 2025 VA/DoD Chronic Insomnia & Obstructive Sleep Apnea Clinical Guideline - Guideline Summary · guidelinecentral.com
- The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea (Insomnia/OSA) (2025) · healthquality.va.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA approved chronic insomnia treatments 2025 daridorexant lemborexant ramelteon doxepin dependence abuse schedule IV OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA prescribing information daridorexant lemborexant abuse dependence schedule IV chronic insomnia OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
AASM clinical practice guideline chronic insomnia CBT-I ramelteon doxepin orexin receptor antagonist OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |